Evidence map›Paper›PMID 31473947›Full record

ReviewHepatology international2019

Radiomics in hepatocellular carcinoma: a quantitative review.

Taiga Wakabayashi, Farid Ouhmich, Cristians Gonzalez-Cabrera, Emanuele Felli, Antonio Saviano, Vincent Agnus, Peter Savadjiev, Thomas F Baumert, Patrick Pessaux, Jacques Marescaux and 1 more

Abstract readReview
In one paragraph

Review in Hepatology international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. BMC cancer · 2025
    Article
  17. Article
  18. Article
  19. BMC cancer · 2024
    Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Taiga WakabayashiInstitut de Recherche Contre les Cancers de l'Appareil Digestif (IRCAD), Strasbourg, France.
Farid OuhmichInstitut hospitalo-universitaire (IHU), Institute for Minimally Invasive Hybrid Image-Guided Surgery, Université de Strasbourg, 1 Place de l'Hôpital, 67000, Strasbourg, France.
Cristians Gonzalez-CabreraInstitut hospitalo-universitaire (IHU), Institute for Minimally Invasive Hybrid Image-Guided Surgery, Université de Strasbourg, 1 Place de l'Hôpital, 67000, Strasbourg, France.
Emanuele FelliInstitut de Recherche Contre les Cancers de l'Appareil Digestif (IRCAD), Strasbourg, France.
Antonio SavianoInstitut hospitalo-universitaire (IHU), Institute for Minimally Invasive Hybrid Image-Guided Surgery, Université de Strasbourg, 1 Place de l'Hôpital, 67000, Strasbourg, France.
Vincent AgnusInstitut hospitalo-universitaire (IHU), Institute for Minimally Invasive Hybrid Image-Guided Surgery, Université de Strasbourg, 1 Place de l'Hôpital, 67000, Strasbourg, France.
Peter SavadjievDepartment of Diagnostic Radiology, McGill University, Montreal, Canada.
Thomas F BaumertInstitut hospitalo-universitaire (IHU), Institute for Minimally Invasive Hybrid Image-Guided Surgery, Université de Strasbourg, 1 Place de l'Hôpital, 67000, Strasbourg, France.
Patrick PessauxInstitut de Recherche Contre les Cancers de l'Appareil Digestif (IRCAD), Strasbourg, France.
Jacques MarescauxInstitut de Recherche Contre les Cancers de l'Appareil Digestif (IRCAD), Strasbourg, France.
Benoit GallixInstitut hospitalo-universitaire (IHU), Institute for Minimally Invasive Hybrid Image-Guided Surgery, Université de Strasbourg, 1 Place de l'Hôpital, 67000, Strasbourg, France. benoit.gallix@ihu-strasbourg.eu.

Funding

ARC, Paris and Institut hospitalo-universitaire TheraHCC IHUARC IHU201301187European Research Council 671231European Union ERC-AdG-2014-671231-HEPCIREuropean Union H2020-667273-HEPCAR
6 · The paper itself

Abstract

Radiomics is an emerging field which extracts quantitative radiology data from medical images and explores their correlation with clinical outcomes in a non-invasive manner. This review aims to assess whether radiomics is a useful and reproducible method for clinical management of hepatocellular carcinoma (HCC) by reviewing the strengths and weaknesses of current radiomics literature pertaining specifically to HCC. From an initial set of 48 articles recovered through database searches, 23 articles were retained to be included in this review after full screening. Among these 23 studies, 7 used a radiomics approach in magnetic resonance imaging (MRI). Only two studies applied radiomics to positron emission tomography-computed tomography (PET-CT). In the remaining 14 articles, a radiomics analysis was performed on computed tomography (CT). Eight studies dealt with the relationship between biological signatures and imaging findings, and can be classified as radiogenomic studies. For each study included in our review, we computed a Radiomics Quality Score (RQS) as proposed by Lambin et al. We found that the RQS (mean ± standard deviation) was 8.35 ± 5.38 (out of a possible maximum value of 36). Although these scores are fairly low, and radiomics has not yet reached clinical utility in HCC, it is important to underscore the fact that these early studies pave the way for the radiomics field with a focus on HCC. Radiomics is still a very young field, and is far from being mature, but it remains a very promising technology for the future for developing adequate personalized treatment as a non-invasive approach, for complementing or replacing tumor biopsies, as well as for developing novel prognostic biomarkers in HCC patients.

Indexed as

Diagnostic ImagingCarcinoma, HepatocellularHumansLiverLiver NeoplasmsTreatment OutcomeHepatocellular carcinomaRadiogenomicsRadiomicsTumor heterogeneity

Identifiers

PMID31473947
PMCPMC7613479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.